Literature DB >> 11777271

Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides.

M Skacel1, J D Pettay, E K Tsiftsakis, G W Procop, C V Biscotti, R R Tubbs.   

Abstract

OBJECTIVE: To evaluate the feasibility of performing multicolor interphase fluorescence in situ hybridization (FISH) on ThinPrep slides of transitional cell carcinoma (TCC). STUDY
DESIGN: Slides from 20 voided urine specimens were prepared by the ThinPrep technique (Cytyc, Boxborough, Massachusetts, U.S.A.), pretreated using a pretreatment kit and subjected to hybridization with the multicolor FISH probe UroVysion (Vysis, Downers Grove, Illinois, U.S.A.). Archival slides were placed in xylene, destained in alcohol and washed prior to pretreatment. Urines from patients with cytology-positive, biopsy-proven grade 1 (n = 5), 2 (n = 7) and 3 (n = 5) TCC and negative cytology and biopsy (n = 3) were selected. Freshly prepared (n = 10) and archival (n = 10) slides were used.
RESULTS: All carcinoma cases were FISH positive (> 5 cells with complex abnormalities of > or = 2 studied chromosomes per slide). None of the normal samples were aneusomic. Gain of chromosomes 3, 7 and 17 constituted the majority of positive cases. Proper destaining and slight decrease in stringency wash conditions enabled reliable detection of signals in archival cases.
CONCLUSION: Routine ThinPrep slides can be used for multicolor interphase FISH analysis of urine cytology specimens. Archival slides provide the opportunity to analyze by FISH the nature of atypical cells identified by cytology. This revised method allows FISH technology more accessibility for routine use in cytology laboratories.

Entities:  

Mesh:

Year:  2001        PMID: 11777271

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  7 in total

1.  Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?

Authors:  F Steffen Krause; Anita Rauch; Karl M Schrott; Dirk G Engehausen
Journal:  World J Urol       Date:  2006-05-11       Impact factor: 4.226

2.  Comparison of liquid based cytology and histology for the evaluation of HER-2 status using immunostaining and CISH in breast carcinoma.

Authors:  H Sartelet; E Lagonotte; M Lorenzato; I Duval; C Lechki; C Rigaud; J Cucherousset; A Durlach; O Graesslin; P Abboud; M Doco-Fenzy; C Quereux; B Costa; M Polette; J-N Munck; P Birembaut
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

3.  Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study.

Authors:  Nancy P Caraway; Abha Khanna; Ricardo L Fernandez; Linda Payne; Roland L Bassett; Hua-Zhong Zhang; Ashish Kamat; Ruth L Katz
Journal:  Cancer Cytopathol       Date:  2010-10-25       Impact factor: 5.284

4.  Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer.

Authors:  Benjamin R Kipp; Mihaela Tanasescu; Terry A Else; Sandra C Bryant; R Jeffrey Karnes; Thomas J Sebo; Kevin C Halling
Journal:  J Mol Diagn       Date:  2009-01-29       Impact factor: 5.568

5.  Integrating a FISH imaging system into the cytology laboratory.

Authors:  G Denice Smith; Matt Riding; Kim Oswald; Joel S Bentz
Journal:  Cytojournal       Date:  2010-04-06       Impact factor: 2.091

Review 6.  Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.

Authors:  Chulso Moon; Maxie Gordon; David Moon; Thomas Reynolds
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

Review 7.  Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?

Authors:  Nada Humayun-Zakaria; Douglas G Ward; Roland Arnold; Richard T Bryan
Journal:  Transl Androl Urol       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.